Evaluation of Clinical Innovation: A Gray Zone in the Ethics of Modern Clinical Practice?

BACKGROUND: Various stakeholders can have differing opinions regarding ethical review when introducing new procedures with patients. OBJECTIVE: This pilot study examines the way in which Research Ethics Boards (REBs; Institutional Review Boards) and clinical biochemists (CBs; laboratory medicine spe...

Descripción completa

Detalles Bibliográficos
Autores principales: Patenaude, Johane, Grant, Andrew M., Xhignesse, Marianne, Leblanc, Frédéric, Courteau, Josiane
Formato: Texto
Lenguaje:English
Publicado: Springer-Verlag 2007
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2150637/
https://www.ncbi.nlm.nih.gov/pubmed/18095040
http://dx.doi.org/10.1007/s11606-007-0410-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2150637/
https://www.ncbi.nlm.nih.gov/pubmed/18095040
http://dx.doi.org/10.1007/s11606-007-0410-2

Ejemplares similares